Franklin Resources
CTKB icon

Franklin Resources’s Cytek Biosciences CTKB Stock Holding History

Franklin Resources’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$691K Buy
156,061
+42,088
+37% +$180K ﹤0.01% 2447
2026
Q1 		$498K Buy
113,973
+103,616
+1,000% +$489K ﹤0.01% 2458
2025
Q4 		$52.3K Sell
10,357
-76,411
-88% -$355K ﹤0.01% 2979
2025
Q3 		$301K Buy
86,768
+10,180
+13% +$38.2K ﹤0.01% 2662
2025
Q2 		$260K Buy
76,588
+444
+0.6% +$1.48K ﹤0.01% 2620
2025
Q1 		$305K Sell
76,144
-107
-0.1% -$555 ﹤0.01% 2480
2024
Q4 		$495K Buy
76,251
+134
+0.2% +$798 ﹤0.01% 2294
2024
Q3 		$405K Buy
+76,117
New +$432K ﹤0.01% 2369

Other funds holding CTKB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Franklin Resources's CTKB Position: Q2 2026 in Review

Franklin Resources increased its Cytek Biosciences (CTKB) stake by 37% in Q2 2026, buying an estimated $180K and bringing the position to 156,061 shares worth $691K. The position accounts for ﹤0.01% of the portfolio, ranked #2447.

Franklin Resources first reported a position in CTKB in Q3 2024 and has held it in 8 quarters since. 155 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • Franklin Resources held 156,061 shares of Cytek Biosciences worth $691K as of Q2 2026.
  • Franklin Resources bought 42,088 Cytek Biosciences shares in Q2 2026, an estimated $180K.
  • Cytek Biosciences made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2447 holding.
  • Franklin Resources first reported a position in Cytek Biosciences in Q3 2024 and has held it in 8 quarters since.
  • 155 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.